3,5-二氯-4-羟基苯肼 | 23964-29-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3,5-二氯-4-羟基苯肼
• 中文别名: 3,5-二氯-4-羟基苯甲酰肼
• 英文名称: 3,5-dichloro-4-hydroxybenzoic acid hydrazide
• 英文别名: 3,5-dichloro-4-hydroxybenzohydrazide
• CAS: 23964-29-6
• 化学式: C₇H₆Cl₂N₂O₂
• mdl: MFCD01661057
• 分子量: 221.043
• InChiKey: YAECGTGIGJYKPO-UHFFFAOYSA-N

物化性质

• 密度：
  1.586±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  75.4
• 氢给体数：
  3
• 氢受体数：
  3

安全信息

• 海关编码：
  2928000090

反应信息

• 作为反应物：
  描述：

  3,5-二氯-4-羟基苯肼 生成 2,6-dichloro-4-(1,3,4-oxadiazol-2-yl)phenol
  参考文献：
  名称：

  DIANA, GUY D.

  摘要：

  DOI：
• 作为产物：
  描述：

  3.5-二氯-4-羟基苯甲酸甲酯 在 一水合肼 作用下， 生成 3,5-二氯-4-羟基苯肼
  参考文献：
  名称：

  Heterocyclic substituted-phenoxyalkylisoxazoles as antiviral useful

  摘要：

  化合物的公式为##STR1##其中：Y是3-9个碳原子的烷基桥；Z是N或HC；R是氢或1-5个碳原子的低烷基，但当Z是N时，R是低烷基；R.sub.1和R.sub.2是氢、卤素、低烷基、低烷氧基、硝基、低烷氧羰基或三氟甲基；Het从指定的杂环基团中选择，对抗病毒剂，特别是对抗小RNA病毒，包括多种鼻病毒菌株。

  公开号：

  US04857539A1

文献信息

• Heterocyclic substituted-phenoxyalkylisoxazoles as antiviral useful
  申请人：Sterling Drug Inc.

  公开号：US04857539A1

  公开（公告）日：1989-08-15

  Compounds of the formula ##STR1## wherein: Y is an alkylene bridge of 3-9 carbon atoms; Z is N or HC; R is hydrogen or lower-alkyl of 1-5 carbon atoms, with the proviso that when Z is N, R is lower-alkyl; R.sub.1 and R.sub.2 are hydrogen, halogen, lower-alkyl, lower-alkoxy, nitro, lower-alkoxycarbonyl or trifluoromethyl; and Het is selected from specified heterocyclic groups, are useful and antiviral agents, particularly against picornaviruses, including numerous strains of rhinovirus.

  化合物的公式为##STR1##其中：Y是3-9个碳原子的烷基桥；Z是N或HC；R是氢或1-5个碳原子的低烷基，但当Z是N时，R是低烷基；R.sub.1和R.sub.2是氢、卤素、低烷基、低烷氧基、硝基、低烷氧羰基或三氟甲基；Het从指定的杂环基团中选择，对抗病毒剂，特别是对抗小RNA病毒，包括多种鼻病毒菌株。
• Compounds, Compositions and Methods Comprising Heteroaromatic Derivatives
  申请人：Doyle Kevin James

  公开号：US20090318429A1

  公开（公告）日：2009-12-24

  The present invention relates to compositions and methods for treating a disease in an animal, which disease is responsive to inhibiting of functional cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide by administering to a mammal in need thereof an effective amount of a compound defined herein (including those compounds set forth in Tables 1-14 or encompassed by formulas I-XII) or compositions thereof, thereby treating the disease. The present invention particularly, relates to a method of treating diarrhea and polycystic kidney disease.

  本发明涉及用于治疗动物患病的组合物和方法，该疾病对通过向需要的哺乳动物投予本文所定义的化合物的有效量（包括表1-14中列出的那些化合物或被I-XII公式所包含的化合物）或其组合物来抑制功能性囊性纤维化跨膜传导调节蛋白（CFTR）多肽作出反应，从而治疗该疾病。本发明特别涉及一种治疗腹泻和多囊性肾病的方法。
• Compounds, Compositions and Methods Comprising 4N-Substituted Triazole Derivatives
  申请人：Russell Michael Geoffrey Neil

  公开号：US20100267725A1

  公开（公告）日：2010-10-21

  The present invention relates to compounds, compositions and methods for treating a disease in an animal, which disease is responsive to inhibiting of functional cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide by administering to a mammal in need thereof an effective amount of a compound defined herein (including those compounds set forth in Table 1 or 2 or encompassed by formula I) or compositions comprising these compounds, thereby treating the disease. The present invention particularly, relates to a method of treating diarrhea and polycystic kidney disease.

  本发明涉及化合物、组合物和治疗动物疾病的方法，该疾病对通过给予需要的哺乳动物有效量的本文中定义的化合物（包括表1或2中列出的那些化合物或公式I所包含的化合物）或包含这些化合物的组合物来抑制功能性囊性纤维化跨膜传导调节蛋白（CFTR）多肽敏感，从而治疗该疾病。本发明特别涉及一种治疗腹泻和多囊性肾病的方法。
• 1,3,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral
  申请人：Sterling Drug Inc.

  公开号：US05110821A1

  公开（公告）日：1992-05-05

  Compounds of the formula ##STR1## wherein: Y is an alkylene bridge of 3-9 carbon atoms; R' is lower-alkyl or hydroxy-lower-alkyl or 1-5 carbon atoms; R.sub.1 and R.sub.2 are hydrogen, halogen, lower-alkyl, lower-alkoxy, nitro, lower-alkoxycarbonyl or trifluoromethyl; and R.sub.8 is hydrogen or lower-alkyl of 1-5 carbon atoms, with the proviso that when R.sub.8 is hydrogen R' is hydroxy-lower-alkyl, are useful as antiviral agents, particularly against picornaviruses, including numerous strains of rhinovirus.

  分子式为##STR1##的化合物，其中：Y是3-9个碳原子的烷基桥；R'是低级烷基或羟基-低级烷基或1-5个碳原子；R.sub.1和R.sub.2是氢、卤素、低级烷基、低级烷氧基、硝基、低级烷氧羰基或三氟甲基；R.sub.8是氢或1-5个碳原子的低级烷基，但当R.sub.8是氢时，R'为羟基-低级烷基，可用作抗病毒剂，特别是对抗小肠病毒，包括大量的鼻病毒菌株。
• Compounds, Compositions and Methods Comprising Triazole Derivatives
  申请人：Russell Michael Geoffrey Neil

  公开号：US20090264471A1

  公开（公告）日：2009-10-22

  The present invention relates to compositions and methods for treating a disease in an animal, which disease is responsive to inhibiting of functional cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide by administering to a mammal in need thereof an effective amount of a compound defined herein (including those compounds set forth in Tables 1-2 or encompassed by formulas I-II) or compositions thereof, thereby treating the disease. The present invention particularly, relates to a method of treating diarrhea and polycystic kidney disease.

  本发明涉及用于治疗动物患病的组合物和方法，该疾病对通过向需要的哺乳动物投予本文所定义的化合物（包括表1-2中列出的那些化合物或由I-II式包围的化合物）或其组合物的有效量以抑制功能性囊性纤维化跨膜传导调节器（CFTR）多肽而做出反应，从而治疗该疾病。本发明特别涉及治疗腹泻和多囊肾病的方法。